Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer

Overview of attention for article published in Frontiers in immunology, September 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

reddit: 1 Redditor

Readers on

mendeley: 4 Mendeley

Summary X Reddit

So far, Altmetric has seen 1 X post from an account with 33,294 followers.

New Research: Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer: Objective This study sought to assess the efficacy and safety of… #immunology https://t.

19 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.